Please login to the form below

Not currently logged in
Email:
Password:

antimicrobial resistance

This page shows the latest antimicrobial resistance news and features for those working in and with pharma, biotech and healthcare.

EMA cuts back as Brexit staff losses top expectations

EMA cuts back as Brexit staff losses top expectations

That means less urgent matters such as harmonisation will be will be dealt with only on a reactive basis, and other topics such as antimicrobial resistance will be considered on a

Latest news

More from news
Approximately 38 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Rules of engagement Rules of engagement

    Fewer than half of the nearly 10, 000 respondents had heard of the term ‘antimicrobial resistance’. ... Only one-fifth were aware of its abbreviated form  ‘AMR’. By contrast, more than two-thirds knew of the terms ‘antibiotic resistance’ or

  • No incentive for a cure No incentive for a cure

    The stakes are too high for this not to happen. The risk we face from antimicrobial resistance and the current lack of new antibiotics tells us all we need to know

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Why this issue is such a fundamental challenge. A look at some of the headline statistics on the antimicrobial resistance (AMR) issue is particularly sobering. ... market. About the AMR Centre. The AMR Centre is a key part of the UK’s response to the

  • Significant figures Significant figures

    us.”. An inhaled formulation of last-resort antibiotic Amikacin, ALIS taps into a need for new antibiotics as well as industry heads towards more joined-up thinking to tackle antimicrobial resistance. ... develop resistance to the macrolide antibiotic,

  • Deal Watch May 2016 Deal Watch May 2016

    Warning that by the year 2050, drug resistant bacteria could kill one person every second across the world, the UK Review on Antimicrobial Resistance recommends a "pay-or-play" system. ... It is suggested that those companies that do not engage in

More from intelligence
Approximately 4 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Navigating the antibiotic resistance crisis

    Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,

  • Antibiotic Resistance: Alarm bells ring louder than ever

    Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be discovered ... where antibiotics and the threat of

  • Cello Health

    Antibiotic Resistance: Alarm bells ring louder than ever. ... Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be

  • Blue Latitude Health

    Navigating the antibiotic resistance crisis. ... Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics